SeaStar Medical (ICU)
SeaStar Medical Statistics
Share Statistics
SeaStar Medical has 8.72M shares outstanding. The number of shares has increased by 180.36% in one year.
| Shares Outstanding | 8.72M |
| Shares Change (YoY) | 180.36% |
| Shares Change (QoQ) | 95.34% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 8.51M |
| Failed to Deliver (FTD) Shares | 1.5K |
| FTD / Avg. Volume | 0.37% |
Short Selling Information
The latest short interest is 357.62K, so 4.1% of the outstanding shares have been sold short.
| Short Interest | 357.62K |
| Short % of Shares Out | 4.1% |
| Short % of Float | 4.2% |
| Short Ratio (days to cover) | 2.38 |
Valuation Ratios
The PE ratio is -0.38 and the forward PE ratio is -1.23. SeaStar Medical's PEG ratio is 0.
| PE Ratio | -0.38 |
| Forward PE | -1.23 |
| PS Ratio | 70.7 |
| Forward PS | 5.5 |
| PB Ratio | -4.37 |
| P/FCF Ratio | -0.6 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for SeaStar Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.55, with a Debt / Equity ratio of -0.26.
| Current Ratio | 0.55 |
| Quick Ratio | 0.55 |
| Debt / Equity | -0.26 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.04 |
| Interest Coverage | -73.12 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $7.11K |
| Profits Per Employee | $-1.31M |
| Employee Count | 19 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 3K |
| Effective Tax Rate | -0.01% |
Stock Price Statistics
The stock price has increased by -92.73% in the last 52 weeks. The beta is -0.9, so SeaStar Medical's price volatility has been lower than the market average.
| Beta | -0.9 |
| 52-Week Price Change | -92.73% |
| 50-Day Moving Average | 1.75 |
| 200-Day Moving Average | 3.7 |
| Relative Strength Index (RSI) | 33.49 |
| Average Volume (20 Days) | 411.04K |
Income Statement
In the last 12 months, SeaStar Medical had revenue of 135K and earned -24.83M in profits. Earnings per share was -5.05.
| Revenue | 135K |
| Gross Profit | 135K |
| Operating Income | -17.84M |
| Net Income | -24.83M |
| EBITDA | -24.58M |
| EBIT | -24.58M |
| Earnings Per Share (EPS) | -5.05 |
Balance Sheet
The company has 1.82M in cash and 574K in debt, giving a net cash position of 1.25M.
| Cash & Cash Equivalents | 1.82M |
| Total Debt | 574K |
| Net Cash | 1.25M |
| Retained Earnings | -139.56M |
| Total Assets | 4.66M |
| Working Capital | -3.08M |
Cash Flow
In the last 12 months, operating cash flow was -16.01M and capital expenditures 0, giving a free cash flow of -16.01M.
| Operating Cash Flow | -16.01M |
| Capital Expenditures | 0 |
| Free Cash Flow | -16.01M |
| FCF Per Share | -3.25 |
Margins
Gross margin is 100%, with operating and profit margins of -13216.3% and -18392.59%.
| Gross Margin | 100% |
| Operating Margin | -13216.3% |
| Pretax Margin | -18390.37% |
| Profit Margin | -18392.59% |
| EBITDA Margin | -18209.63% |
| EBIT Margin | -13216.3% |
| FCF Margin | -11857.04% |
Dividends & Yields
ICU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ICU.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jun 10, 2024. It was a backward split with a ratio of 1:25.
| Last Split Date | Jun 10, 2024 |
| Split Type | backward |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | -63.19 |
| Piotroski F-Score | 5 |